RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30163% above fair value

$1.16−0.06 (-4.92%)

Close on Nov 12, 2026Market cap $52.35MP/E –Yield –

RenovoRx EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

RenovoRx's EPS for the twelve months ending Sep 30, 2026 was -$0.31. For fiscal 2025 it was -$0.32. The highest annual figure on record is -$0.32 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$0.32	–
FY2024	Dec 31, 2024	-$0.40	–
FY2023	Dec 31, 2023	-$0.99	–
FY2022	Dec 31, 2022	-$1.09	–
FY2021	Dec 31, 2021	-$1.21	–
FY2020	Dec 31, 2020	-$1.72	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.08	–
Q2 FY2026	Jun 30, 2026	-$0.06	–
Q1 FY2026	Mar 31, 2026	-$0.09	–
Q4 FY2025	Dec 31, 2025	-$0.08	–
Q3 FY2025	Sep 30, 2025	-$0.08	–
Q2 FY2025	Jun 30, 2025	-$0.08	–
Q1 FY2025	Mar 31, 2025	-$0.08	–
Q4 FY2024	Dec 31, 2024	-$0.11	–
Q3 FY2024	Sep 30, 2024	-$0.10	–
Q2 FY2024	Jun 30, 2024	-$0.10	–
Q1 FY2024	Mar 31, 2024	-$0.07	–
Q4 FY2023	Dec 31, 2023	-$0.30	–
Q3 FY2023	Sep 30, 2023	-$0.13	–
Q2 FY2023	Jun 30, 2023	-$0.22	–
Q1 FY2023	Mar 31, 2023	-$0.36	–
Q4 FY2022	Dec 31, 2022	-$0.24	–
Q3 FY2022	Sep 30, 2022	-$0.24	–
Q2 FY2022	Jun 30, 2022	-$0.29	–
Q1 FY2022	Mar 31, 2022	-$0.33	–
Q3 FY2021	Sep 30, 2021	-$0.27	–
Q4 FY2020	Dec 31, 2020	-$0.41	–
Q3 FY2020	Sep 30, 2020	-$0.48	–